Carcinogenesis models for risk assessment

Statistical Methods in Medical Research

Volumn 6, Issue 4, 1997, Pages 317-340

  Kopp Schneider, Annette ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN;

BIOLOGICAL MODEL; DOSE RESPONSE; HUMAN; NEOPLASM; ONCOGENESIS AND MALIGNANT TRANSFORMATION; PATHOPHYSIOLOGY; REVIEW; RISK ASSESSMENT;

CARCINOGENS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NEOPLASTIC PROCESSES; RISK ASSESSMENT;

EID: 0031302641     PISSN: 09622802     EISSN: None     Source Type: Journal    
DOI: 10.1177/096228029700600403     Document Type: Article

References (63)

1. Johnson NL, Kotz S. Continuous univariate distributions - I. Boston, MA: Houghton Mifflin, 1970.
2. Matsushita S, Hagiwara K, Shiota T, Shimada H, Kuramoto K, Toyokura Y. Lifetime data analysis of disease and aging by the Weibull probability distribution. Journal of Clinical Epidemiology 1992; 45: 1165-75.
3. Kopp-Schneider A, Portier CJ. Distinguishing between models of carcinogenesis: the role of clonal expansion. Fundamental and Applied Toxicology 1991; 17: 601-13.
4. Becker N. Reliability models in cancer epidemiology. Biometrical Journal 1989; 31: 727-48.
5. Becker N, Rittgen W. Some mathematical properties of CD models regarding their application in cancer epidemiology. Biometrical Journal 1990; 32: 3-15.
6. Tautu P. Carcinogenesis theory revisited: reliability models avenue. Proceedings of the 9th International Biometric Conference 1976; II: 110-24.
7. Becker N, Rittgen W. Fitting epidemiologic follow-up studies with cumulative damage models. Mathematical Biosciences 1994; 120: 147-63.
8. Klebanov LB, Rachev ST, Yakovlev AY. A stochastic model of radiation carcinogenesis: latent time distributions and their properties. Mathematical Biosciences 1993; 113: 51-75.
9. Yakovlev AY, Tsodikov AD. Stochastic models of tumor latency and their biostatistical applications. Singapore: World Scientific, 1996.
10. Schürger K, Tautu P. A Markovian configuration model for carcinogenesis. In: Berger J , Bühler W, Repges R, Tautu P eds. Mathematical models in medicine. Lecture Notes in Biomathematics. Berlin: Springer, 1976; 11: 92-108.
11. Pilz L, Rittgen W. Growth of foci in a biological cell configuration. In: Proceedings of the 12th IASTED International Conference. Zürich: Acta Press, 1993: 349-53.
12. Whittemore A, Keller JB. Quantitative theories of carcinogenesis. SIAM 1978; 20: 1-30.
13. Iversen S, Arley N. On the mechanism of experimental carcinogenesis. Acta Pathologica et Microbiologica Scandinavica 1950; 27: 773-803.
14. Fisher JC, Holoman JH. A hypothesis for the origin of cancer. Cancer 1951; 4: 916-18.
15. Nordling CO. A new theory on the cancer inducing mechanism. British Journal of Cancer 1953; 7: 68-72.
16. Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. British Journal of Cancer 1954; 8: 1-12.
17. Berenblum I, Shubik P. The role of croton oil application associated with a single pointing of a carcinogen in tumor induction of the mouse's skin. British Journal of Cancer 1947; 1: 379-91.
18. Armitage P, Doll R. A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. British Journal of Cancer 1957; 11: 161-69.
19. Kendall DG. Birth-and-death processes, and the theory of carcinogenesis. Biometrika 1960; 47: 316-30.
20. Neyman J, Scott E. Statistical aspects of the problem of carcinogenesis. Fifth Berkeley symposium on mathematical statistics and probability. Berkeley, CA: University of California Press, 1967: 745-76.
21. Moolgavkar SH, Venzon DJ. Two-event model for carcinogenesis: incidence curves for childhood and adult tumors. Mathematical Biosciences 1979; 47: 55-77.
22. Moolgavkar SH, Knudson AG. Mutation and cancer: a model for human carcinogenesis. Journal of the National Cancer Institute 1981; 66: 1037-52.
23. Moolgavkar SH, Cross FT, Luebeck G, Deagle GE. A two-mutation model for radon-induced lung tumors in rats. Radiation Research 1990; 121: 28-37.
24. Moolgavkar SH, Luebeck EG. Multistage carcinogenesis: population-based model for colon cancer. Journal of the National Cancer Institute 1992; 84: 610-18.
25. Tan WY. Stochastic models of carcinogenesis. Statistics, textbooks and monographs, vol 116. New York: Marcel Dekker, 1991.
26. Moolgavkar SH, Luebeck EG, de Gunst M, Port RE, Schwarz M. Quantitative analysis of enzyme-altered foci in rat hepatocarcinogenesis experiments I: single agent regimen. Carcinogenesis 1990; 11: 1271-78.
27. Kopp-Schneider A, Portier CJ. Birth and death/differentiation rates of papillomas in mouse skin. Carcinogenesis 1992; 13: 973-78.
28. Kopp-Schneider A., Portier CJ. Carcinoma formation in NMRI mouse skin painting studies is a process suggesting greater than two stages. Carcinogenesis 1995; 16: 53-59.
29. Portier CJ, Kopp-Schneider A. A multistage model of carcinogenesis incorporating DNA damage and repair. Risk Analysis 1991; 11: 535-43.
30. Kopp-Schneider A Portier CJ, Rippmann F. The application of a multistage model which incorporates DNA damage and repair to the analysis of initiation/promotion experiments. Mathematical Biosciences 1991; 105: 139-66.
31. Kopp-Schneider A, Portier CJ. A stem cell model for carcinogenesis. Mathematical Biosciences 1994; 120: 211-32.
32. Feller W. An introduction to probability theory and its applications, 3rd edition, vol I. New York: John Wiley, 1968.
33. Portier CJ, Kopp-Schneider A, Sherman CD. Estimating tumor incidence rates in stochastic models of carcinogenesis. Mathematical Biosciences 1996; 135: 129-46.
34. Parzen E. Stochastic processes. San Francisco, CA: Holden-Day, 1962.
35. Tan WY. A stochastic Gompertz birth-death process. Statistics and Probability Letters 1986; 4: 25-28.
36. Kopp-Schneider A. Birth-death processes with piecewise constant rates. Statistics and Probability Letters 1992; 13: 121-27.
37. Moolgavkar SH. The multistage theory of carcinogenesis and the age distribution of cancer in man. Journal of the National Cancer Institute 1978; 61: 49-52.
38. Zheng Q. On the exact hazard and survival functions of the MVK stochastic carcinogenesis model. Risk Analysis 1994; 14: 1081-84.
39. Kopp-Schneider A, Portier CJ, Sherman CD. The exact formula for tumor incidence in the two-stage model. Risk Analysis 1994; 14: 1079-80.
40. Heidenreich WF. On the parameters of the clonal expansion model. Radiation and Environmental Biophysics 1996; 35: 127-29.
41. Hanin LG, Yakovlev, AY. A nonidentifiability aspect of the two-stage model of carcinogenesis. Risk Analysis 1996; 16: 711-15.
42. Denes J, Krewski D. An exact representation for the generating function for the Moolgavkar-Venzon-Knudson two-stage model of carcinogenesis with stochastic stem cell growth. Mathematical Biosciences 1996; 131: 185-204.
43. Thorslund TW, Brown CC, Charnley G. Biologically motivated cancer risk models. Risk Analysis 1987; 7: 109-19.
44. Murdoch DJ, Krewski D. Carcinogenic risk assessment with time-dependent exposure patterns. Risk Analysis 1988; 8: 521-30.
45. Moolgavkar SH, Dewanji A, Venzon DJ. A stochastic two-stage model for cancer risk assessment. I. The hazard function and probability of tumor. Risk Analysis 1988; 8: 383-92.
46. Kopp A, Portier CJ. A note on approximating the cumulative distribution function of the time to tumor onset in multistage models. Biometrics 1989; 45: 1259-63.
47. Hindmarsh AC. LSODE and LSODI, two new initial value ordinary differential equation solvers. ACM-SIGNUM Newsletter 1980; 15: 10-11.
48. Dewanji A, Venzon DJ, Moolgavkar SH. A stochastic two-stage model for cancer risk assessment. II. The number and size of premalignant clones. Risk Analysis 1989; 9: 179-87.
49. Portier CJ. Statistical properties of a two-stage model of carcinogenesis. Environmental Health Perspectives 1987; 76: 125-31.
50. Whittemore AS. The age distribution of human cancers for carcinogenic exposures of varying intensity. American Journal of Epidemiology 1977; 106: 418-32.
51. Day NE, Brown CC. Multistage models and primary prevention of cancer. Journal of the National Cancer Institute 1980; 64: 977-89.
52. Brown CC, Chu KC. Additive and multiplicative models and multistage carcinogenesis theory. Risk Analysis 1989; 9: 99-105.
53. Thorslund TW, Brown CC, Charnley G. Biologically motivated cancer risk models. Risk Analysis 1987; 7: 109-19.
54. Kodell RL, Krewski D, Zielinski JM. Additive and multiplicative relative risk in the two-stage clonal expansion model of carcinogenesis. Risk Analysis 1991; 11: 483-90.
55. US Environmental Protection Agency. Proposed guidelines for carcinogen risk assessment. Federal Register 1996; 61: 17960-8011.
56. Crump KS. Limitations of biological models of carcinogenesis for low-dose extrapolation. Risk Analysis 1994; 14: 883-86.
57. Crump KS. Use of mechanistic models to estimate low-dose cancer risks. Risk Analysis 1994; 14: 1033-38.
58. Portier CJ, Sherman CD, Kohn M, Edler L, Kopp-Schneider A, Maronpot RM, Lucier G. Modeling the number and size of hepatic focal lesions following exposure to 2,3,7,8-TCDD. Toxicology and Applied Pharmacology 1996; 138, 20-30.
59. Moolgavkar SH, Luebeck EG, Buchmann A, Bock KW. Quantitative analysis of enzyme-altered liver foci in rats initiated with diethylnitrosamine and promoted with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 1,2,3,4,5,7,8-heptachlorodibenzo-p-dioxin. Toxicology and Applied Pharmacology 1996; 138: 31-42.
60. Crump KS. A new method for determining allowable daily intakes. Fundamental and Applied Toxicology 1984; 4: 854-71.
61. Barnes DG, Daston GP, Evans JS et al. Benchmark dose workshop: criteria for use of a benchmark dose to estimate a reference dose. Regulatory Toxicology and Pharmacology 1995; 21: 296-306.
62. Moolgavkar SH. Biological models of carcinogenesis and quantitative cancer risk assessment. Risk Analysis 1994; 14: 879-82.
63. Goddard MJ, Krewski D. The future of mechanistic research in risk assessment: where are we going and can we get there from here? Toxicology 1995; 102: 53-70.